FDA Expands Use of Pembrolizumab to Two Additional Cancer Types
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
January is Cervical Cancer Awareness Month. It’s a time to celebrate progress against a disease that was once a...
Cancer awareness months provide an opportunity to increase public knowledge of all aspects of a particular cancer, from prevention,...